SPRY
Ars Pharmaceuticals Inc
Biopharmaceutical company developing treatments for severe allergic reactions
CUSIP: 82835W108HealthcareUS1 holder
Recent Activity
2025Q4
1 buy
+556.2K shares
+556.2K shares
Ars Pharmaceuticals Inc
Biopharmaceutical company developing treatments for severe allergic reactions